Global Urinalysis Test Market Research Report—Forecast till 2025
出 版 商：Market Research Future
出版日期：2020/12/01
頁 數：141頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Urinalysis Test Market: Information by Product Type (Consumables and Instruments), By Test Type (Sediment Analysis and Biochemical Analysis), By Application (Disease Diagnosis and Pregnancy & Fertility), By End User (Hospitals and Clinics, Diagnostic Laboratories and Home Care Settings) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
Market analysis
Generally, Urinalysis testing involves a series of tests for the diagnosis of common diseases. The sample may be observed for color, cloudiness, concentration, signs of drug use, and chemical composition, including glucose, the presence of protein, blood cells, or germ, or other signs of disease. These diseases are inclusive of urinary tract infections, kidney disorders, diabetes, and other problems. Urinalysis refers to the analysis of urine samples for diagnosis in pathological laboratories. Other features such as the rising prevalence of diabetes, rising incidence of kidney diseases, a mounting number of research organizations and associations for diabetes, increasing geriatric population, and the influence of sedentary lifestyle and unhealthy diet are pouring the urinalysis test market. However, factors such as limited indications of urinalysis tests and stringent reimbursement policies in developing countries are hampering the growth of the market. Also, the increasing number of research organizations creating awareness about various diagnostic tests for diabetes is projected to drive the growth of the market. The increasing occurrences of chronic kidney diseases (CKD) and diabetes globally, coupled with the upcoming activities by key players such as product launches and approvals, are projected to positively impact to the growth of the global urinalysis test market.
Market segmentation
The Global Urinalysis Test Market is segmented into product type, test type, application and end user respectively. Based on the test type, the urinalysis test market has been categorized as pregnancy and fertility tests, biochemical analysis, and sediment analysis. The sediment analysis segment is likely to hold a substantial market share during the next seven years owing to the rising adoption of urinary sediment examination to precisely classify and measure urine machineries, such as epithelial cells, non-epithelial cells (blood cells), salts or crystals, casts, and microorganisms. Based on product type, the urinalysis test market has been classified as consumables and devices. The consumables segment has been further apportioned into pregnancy & fertility kits, dipsticks, disposables, and reagents. The consumables segment is expected to command the market over the review period owing to the repetitive use of consumables during urinalysis practices. By end user, the global urinalysis test market has been segmented into hospitals and clinics, diagnostic laboratories, home care settings, and others. The hospitals and clinics sector would lead the market throughout the forecast period since urine analysis has become a part of the general checkup in hospitals and clinics as well as a high number of urinalysis procedures are associated with these healthcare facilities. On the basis of application, the global urinalysis test market has been segregated into disease diagnosis, pregnancy and fertility, and others. The disease diagnosis segment spearheaded the market in 2018 attributed to facts such as the rising prevalence of urinary tract infections, diabetes, and kidney diseases along with rising implementation of urinalysis tests, and the overview of technologically progressive, rapid, non-invasive, and user-friendly tools for urinalysis.
Regional analysis
Geographically the Global Urinalysis Test Market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The Americas was the largest market for urinalysis tests in 2018 due to the rising demand for automated urine analyzers, technological advancements in urinalysis test instruments, and rising incidence of kidney and liver diseases in the US and Canada. In North America, the US held the largest share of the market in 2018 owing to the presence of significant players focused on producing urine analyzers and consumables, rising research actions in the field of urinalysis, and growing awareness about customized medications.
Major players
The proposed spectators in the Global Urinalysis Test Market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Urinalysis Test Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Urinalysis Test Market are companies like Bio-Rad Laboratories (US), Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US), URIT Medical Electronic Ltd (China) and Arkray Inc. (Japan).
Market analysis
Generally, Urinalysis testing involves a series of tests for the diagnosis of common diseases. The sample may be observed for color, cloudiness, concentration, signs of drug use, and chemical composition, including glucose, the presence of protein, blood cells, or germ, or other signs of disease. These diseases are inclusive of urinary tract infections, kidney disorders, diabetes, and other problems. Urinalysis refers to the analysis of urine samples for diagnosis in pathological laboratories. Other features such as the rising prevalence of diabetes, rising incidence of kidney diseases, a mounting number of research organizations and associations for diabetes, increasing geriatric population, and the influence of sedentary lifestyle and unhealthy diet are pouring the urinalysis test market. However, factors such as limited indications of urinalysis tests and stringent reimbursement policies in developing countries are hampering the growth of the market. Also, the increasing number of research organizations creating awareness about various diagnostic tests for diabetes is projected to drive the growth of the market. The increasing occurrences of chronic kidney diseases (CKD) and diabetes globally, coupled with the upcoming activities by key players such as product launches and approvals, are projected to positively impact to the growth of the global urinalysis test market.
Market segmentation
The Global Urinalysis Test Market is segmented into product type, test type, application and end user respectively. Based on the test type, the urinalysis test market has been categorized as pregnancy and fertility tests, biochemical analysis, and sediment analysis. The sediment analysis segment is likely to hold a substantial market share during the next seven years owing to the rising adoption of urinary sediment examination to precisely classify and measure urine machineries, such as epithelial cells, non-epithelial cells (blood cells), salts or crystals, casts, and microorganisms. Based on product type, the urinalysis test market has been classified as consumables and devices. The consumables segment has been further apportioned into pregnancy & fertility kits, dipsticks, disposables, and reagents. The consumables segment is expected to command the market over the review period owing to the repetitive use of consumables during urinalysis practices. By end user, the global urinalysis test market has been segmented into hospitals and clinics, diagnostic laboratories, home care settings, and others. The hospitals and clinics sector would lead the market throughout the forecast period since urine analysis has become a part of the general checkup in hospitals and clinics as well as a high number of urinalysis procedures are associated with these healthcare facilities. On the basis of application, the global urinalysis test market has been segregated into disease diagnosis, pregnancy and fertility, and others. The disease diagnosis segment spearheaded the market in 2018 attributed to facts such as the rising prevalence of urinary tract infections, diabetes, and kidney diseases along with rising implementation of urinalysis tests, and the overview of technologically progressive, rapid, non-invasive, and user-friendly tools for urinalysis.
Regional analysis
Geographically the Global Urinalysis Test Market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. The Americas was the largest market for urinalysis tests in 2018 due to the rising demand for automated urine analyzers, technological advancements in urinalysis test instruments, and rising incidence of kidney and liver diseases in the US and Canada. In North America, the US held the largest share of the market in 2018 owing to the presence of significant players focused on producing urine analyzers and consumables, rising research actions in the field of urinalysis, and growing awareness about customized medications.
Major players
The proposed spectators in the Global Urinalysis Test Market are manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Urinalysis Test Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Urinalysis Test Market are companies like Bio-Rad Laboratories (US), Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US), URIT Medical Electronic Ltd (China) and Arkray Inc. (Japan).
TABLE OF CONTENTS
1 Executive Summary
1.1 MARKET SYNOPSIS 22
1.2 MARKET ATTRACTIVENESS ANALYSIS 23
1.3 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE 24
1.4 GLOBAL URINALYSIS TEST MARKET, BY TEST TYPE 25
1.5 GLOBAL URINALYSIS TEST MARKET, BY APPLICATION 26
1.6 GLOBAL URINALYSIS TEST MARKET, BY END USER 27
2 Market Introduction
2.1 DEFINITION 28
2.2 SCOPE OF THE STUDY 28
2.3 RESEARCH OBJECTIVE 28
2.4 MARKET STRUCTURE 28
2.5 ASSUMPTIONS & LIMITATIONS 29
3 Research Methodology
3.1 DATA MINING 30
3.2 SECONDARY RESEARCH 31
3.3 PRIMARY RESEARCH 32
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 33
3.5 FORECASTING TECHNIQUES 34
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 35
3.6.1 BOTTOM-UP APPROACH 36
3.6.2 TOP-DOWN APPROACH 36
3.7 DATA TRIANGULATION 37
3.8 VALIDATION 37
4 MARKET DYNAMICS
4.1 OVERVIEW 38
4.2 DRIVERS 39
4.2.1 RISING PREVALENCE OF DIABETES 39
4.2.2 RISING PREVALENCE OF KIDNEY DISEASES 39
4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 39
4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 40
4.3 RESTRAINTS 41
4.3.1 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 41
4.3.2 SUPPLY OF DEFECTIVE AND FAULTY PRODUCTS 41
4.4 OPPORTUNITIES 42
4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 42
4.4.2 EXPANSION IN DEVELOPING ECONOMIES 42
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 43
5.1.1 THREAT OF NEW ENTRANTS 43
5.1.2 BARGAINING POWER OF SUPPLIERS 44
5.1.3 THREAT OF SUBSTITUTES 44
5.1.4 BARGAINING POWER OF BUYERS 44
5.1.5 INTENSITY OF RIVALRY 44
5.2 VALUE CHAIN ANALYSIS 45
5.2.1 R&D AND DESIGNING 45
5.2.2 MANUFACTURING 45
5.2.3 DISTRIBUTION 46
5.2.4 MARKETING & SALES 46
5.2.5 POST-SALES MONITORING 46
6 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 47
6.2 CONSUMABLES 48
6.2.1 PREGNANCY & FERTILITY KITSC 49
6.2.2 DIPSTICKS 50
6.2.3 DISPOSABLES REAGENTS 50
6.2.4 REAGENTS 51
6.3 INSTRUMENTS 51
6.3.1 AUTOMATED URINE ANALYZERS 52
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 56
6.3.3 POINT-OF-CARE URINE ANALYZERS 57
7 GLOBAL URINALYSIS TEST MARKET, TEST TYPE
7.1 OVERVIEW 58
7.2 SEDIMENT ANALYSIS 59
7.3 BIOCHEMICAL ANALYSIS 60
7.3.1 LABORATORY TESTS 61
7.3.2 POINT-OF-CARE TESTS 61
7.4 PREGNANCY AND FERTILITY TESTS 62
8 GLOBAL URINALYSIS TEST MARKET, APPLICATION
8.1 OVERVIEW 63
8.2 DISEASE DIAGNOSIS 64
8.2.1 KIDNEY DISEASES 65
8.2.2 DIABETES 66
8.2.3 URINARY TRACT INFECTIONS 67
8.3 PREGNANCY & FERTILITY 68
9 GLOBAL URINALYSIS TEST MARKET, END USER
9.1 OVERVIEW 69
9.2 HOSPITALS AND CLINICS 70
9.3 DIAGNOSTIC LABORATORIES 71
9.4 HOME CARE SETTINGS 72
9.5 OTHERS 72
10 GLOBAL URINALYSIS TEST MARKET, BY REGION
10.1 OVERVIEW 73
10.2 AMERICAS 75
10.2.1 NORTH AMERICA 80
10.2.2 LATIN AMERICA 93
10.3 EUROPE 98
10.3.1 WESTERN EUROPE 103
10.3.2 EASTERN EUROPE 134
10.4 ASIA-PACIFIC 139
10.4.1 CHINA 144
10.4.2 JAPAN 148
10.4.3 INDIA 152
10.4.4 AUSTRALIA 157
10.4.5 SOUTH KOREA 161
10.4.6 REST OF ASIA-PACIFIC 165
10.5 MIDDLE EAST & AFRICA 170
10.5.1 MIDDLE EAST 175
10.5.2 AFRICA 179
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 183
11.2 COMPETITIVE BENCHMARKING 184
11.3 GLOBAL URINALYSIS TEST MARKET, COMPANY SHARE ANALYSIS, 2018 186
11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL URINALYSIS TEST MARKET 186
11.5 KEY DEVELOPMENT ANALYSIS 187
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 187
11.6.1 CONTRACTS & AGREEMENTS 187
11.6.2 MERGER & ACQUISITION 188
11.6.3 NEW PRODUCT LAUNCH 188
11.6.4 EXPANSIONS 188
11.6.5 APPROVALS 189
12 COMPANY PROFILES
12.1 ABBOTT LABORATORIES 190
12.1.1 COMPANY OVERVIEW 190
12.1.2 FINANCIAL OVERVIEW 190
12.1.3 PRODUCTS/SERVICES OFFERED 191
12.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 191
12.1.5 SWOT ANALYSIS 191
12.1.6 KEY STRATEGIES 191
12.2 BIO-RAD LABORATORIES, INC. 192
12.2.1 COMPANY OVERVIEW 192
12.2.2 FINANCIAL OVERVIEW 192
12.2.3 PRODUCTS/SERVICES OFFERED 193
12.2.4 KEY DEVELOPMENTS 193
12.2.5 SWOT ANALYSIS 193
12.2.6 KEY STRATEGIES 194
12.3 BECKMAN COULTER INC. 195
12.3.1 COMPANY OVERVIEW 195
12.3.2 FINANCIAL OVERVIEW 195
12.3.3 PRODUCTS/SERVICES OFFERED 196
12.3.4 KEY DEVELOPMENTS 196
12.3.5 SWOT ANALYSIS 196
12.3.6 KEY STRATEGIES 197
12.4 F. HOFFMANN-LA ROCHE LTD 198
12.4.1 COMPANY OVERVIEW 198
12.4.2 FINANCIAL OVERVIEW 198
12.4.3 PRODUCTS/SERVICES OFFERED 199
12.4.4 KEY DEVELOPMENTS 199
12.4.5 SWOT ANALYSIS 199
12.4.6 KEY STRATEGIES 199
12.5 SIEMENS HEALTHINEERS 200
12.5.1 COMPANY OVERVIEW 200
12.5.2 FINANCIAL OVERVIEW 200
12.5.3 PRODUCTS/SERVICES OFFERED 201
12.5.4 KEY DEVELOPMENTS 201
12.5.5 SWOT ANALYSIS 202
12.5.6 KEY STRATEGIES 202
12.6 EKF DIAGNOSTICS 203
12.6.1 COMPANY OVERVIEW 203
12.6.2 FINANCIAL OVERVIEW 203
12.6.3 PRODUCTS/SERVICES OFFERED 204
12.6.4 KEY DEVELOPMENTS 204
12.6.5 SWOT ANALYSIS 204
12.6.6 KEY STRATEGIES 205
12.7 ARKRAY, INC. 206
12.7.1 COMPANY OVERVIEW 206
12.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 206
12.7.3 PRODUCTS/SERVICES OFFERED 206
12.7.4 KEY DEVELOPMENTS 206
12.7.5 SWOT ANALYSIS 207
12.7.6 KEY STRATEGIES 207
12.8 TRINITY BIOTECH PLC 208
12.8.1 COMPANY OVERVIEW 208
12.8.2 FINANCIAL OVERVIEW 208
12.8.3 PRODUCTS/SERVICES OFFERED 209
12.8.4 KEY DEVELOPMENTS 209
12.8.5 SWOT ANALYSIS 209
12.8.6 KEY STRATEGIES 209
12.9 ANALYTICON BIOTECHNOLOGIES AG 210
12.9.1 COMPANY OVERVIEW 210
12.9.2 FINANCIAL OVERVIEW 210
12.9.3 PRODUCTS/SERVICES OFFERED 210
12.9.4 KEY DEVELOPMENTS 210
12.9.5 SWOT ANALYSIS 211
12.9.6 KEY STRATEGIES 211
12.10 77 ELEKTRONIKA KFT. 212
12.10.1 COMPANY OVERVIEW 212
12.10.2 FINANCIAL OVERVIEW 212
12.10.3 PRODUCTS/SERVICES OFFERED 212
12.10.4 KEY DEVELOPMENTS 212
12.10.5 SWOT ANALYS 213
12.10.6 KEY STRATEGIES 213
12.11 YD DIAGNOSTICS 214
12.11.1 COMPANY OVERVIEW 214
12.11.2 FINANCIAL OVERVIEW 214
12.11.3 PRODUCTS/SERVICES OFFERED 214
12.11.4 KEY DEVELOPMENTS 214
12.11.5 SWOT ANALYSIS 215
12.11.6 KEY STRATEGIES 215
12.12 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD 216
12.12.1 COMPANY OVERVIEW 216
12.12.2 FINANCIAL OVERVIEW 216
12.12.3 PRODUCTS/SERVICES OFFERED 216
12.12.4 KEY DEVELOPMENTS 216
12.12.5 SWOT ANALYS 217
12.12.6 KEY STRATEGIES 217
12.13 ERBA MANNHEIM 218
12.13.1 COMPANY OVERVIEW 218
12.13.2 FINANCIAL OVERVIEW 218
12.13.3 PRODUCTS/SERVICES OFFERED 218
12.13.4 KEY DEVELOPMENTS 218
12.13.5 SWOT ANALYS 219
12.13.6 KEY STRATEGIES 219
12.14 CARDINAL HEALTH 220
12.14.1 COMPANY OVERVIEW 220
12.14.2 FINANCIAL OVERVIEW 220
12.14.3 PRODUCTS/SERVICES OFFERED 221
12.14.4 KEY DEVELOPMENTS 221
12.14.5 SWOT ANALYSIS 221
12.14.6 KEY STRATEGY 221
12.15 THERMO FISHER SCIENTIFIC INC. 222
12.15.1 COMPANY OVERVIEW 222
12.15.2 FINANCIAL OVERVIEW 222
12.15.3 PRODUCTS/SERVICES OFFERED 223
12.15.4 KEY DEVELOPMENTS 223
12.15.5 SWOT ANALYSIS 223
12.15.6 KEY STRATEGIES 223
12.16 QUIDEL CORPORATION 224
12.16.1 COMPANY OVERVIEW 224
12.16.2 FINANCIAL OVERVIEW 224
12.16.3 PRODUCTS/SERVICES OFFERED 225
12.16.4 KEY DEVELOPMENTS 225
12.16.5 SWOT ANALYSIS 225
12.16.6 KEY STRATEGIES 225
12.17 SYSMEX CORPORATION 226
12.17.1 COMPANY OVERVIEW 226
12.17.2 FINANCIAL OVERVIEW 226
12.17.3 PRODUCTS/SERVICES OFFERED 227
12.17.4 KEY DEVELOPMENTS 227
12.17.5 SWOT ANALYS 227
12.17.6 KEY STRATEGIES 228
12.18 ACON LABORATORIES, INC. 229
12.18.1 COMPANY OVERVIEW 229
12.18.2 FINANCIAL OVERVIEW 229
12.18.3 PRODUCTS/SERVICES OFFERED 229
12.18.4 KEY DEVELOPMENTS 229
12.18.5 SWOT ANALYSIS 230
12.18.6 KEY STRATEGIES 230
12.19 BECTON, DICKINSON AND COMPANY 231
12.19.1 COMPANY OVERVIEW 231
12.19.2 FINANCIAL OVERVIEW 231
12.19.3 PRODUCTS/SERVICES OFFERED 232
12.19.4 KEY DEVELOPMENTS 232
12.19.5 SWOT ANALYS 232
12.19.6 KEY STRATEGIES 232
12.20 URIT MEDICAL ELECTRONIC C0., LTD 233
12.20.1 COMPANY OVERVIEW 233
12.20.2 FINANCIAL OVERVIEW 233
12.20.3 PRODUCTS/SERVICES OFFERED 233
12.20.4 KEY DEVELOPMENTS 233
12.20.5 SWOT ANALYSIS 234
12.20.6 KEY STRATEGIES 234
12.21 DIRUI 235
12.21.1 COMPANY OVERVIEW 235
12.21.2 FINANCIAL OVERVIEW 235
12.21.3 PRODUCTS/SERVICES OFFERED 235
12.21.4 KEY DEVELOPMENTS 235
12.21.5 SWOT ANALYS 236
12.21.6 KEY STRATEGIES 236
13 APPENDIX
13.1 REFERENCES 237
13.2 RELATED REPORTS 237
1 Executive Summary
1.1 MARKET SYNOPSIS 22
1.2 MARKET ATTRACTIVENESS ANALYSIS 23
1.3 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE 24
1.4 GLOBAL URINALYSIS TEST MARKET, BY TEST TYPE 25
1.5 GLOBAL URINALYSIS TEST MARKET, BY APPLICATION 26
1.6 GLOBAL URINALYSIS TEST MARKET, BY END USER 27
2 Market Introduction
2.1 DEFINITION 28
2.2 SCOPE OF THE STUDY 28
2.3 RESEARCH OBJECTIVE 28
2.4 MARKET STRUCTURE 28
2.5 ASSUMPTIONS & LIMITATIONS 29
3 Research Methodology
3.1 DATA MINING 30
3.2 SECONDARY RESEARCH 31
3.3 PRIMARY RESEARCH 32
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 33
3.5 FORECASTING TECHNIQUES 34
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 35
3.6.1 BOTTOM-UP APPROACH 36
3.6.2 TOP-DOWN APPROACH 36
3.7 DATA TRIANGULATION 37
3.8 VALIDATION 37
4 MARKET DYNAMICS
4.1 OVERVIEW 38
4.2 DRIVERS 39
4.2.1 RISING PREVALENCE OF DIABETES 39
4.2.2 RISING PREVALENCE OF KIDNEY DISEASES 39
4.2.3 GROWING NUMBER OF RESEARCH ORGANIZATIONS AND ASSOCIATIONS FOR DIABETES 39
4.2.4 INCREASING GERIATRIC POPULATION AND THE INFLUENCE OF SEDENTARY LIFESTYLE AND UNHEALTHY DIET 40
4.3 RESTRAINTS 41
4.3.1 STRINGENT REIMBURSEMENT POLICIES IN DEVELOPING COUNTRIES 41
4.3.2 SUPPLY OF DEFECTIVE AND FAULTY PRODUCTS 41
4.4 OPPORTUNITIES 42
4.4.1 INCREASING APPROVALS AND PRODUCT LAUNCHES 42
4.4.2 EXPANSION IN DEVELOPING ECONOMIES 42
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 43
5.1.1 THREAT OF NEW ENTRANTS 43
5.1.2 BARGAINING POWER OF SUPPLIERS 44
5.1.3 THREAT OF SUBSTITUTES 44
5.1.4 BARGAINING POWER OF BUYERS 44
5.1.5 INTENSITY OF RIVALRY 44
5.2 VALUE CHAIN ANALYSIS 45
5.2.1 R&D AND DESIGNING 45
5.2.2 MANUFACTURING 45
5.2.3 DISTRIBUTION 46
5.2.4 MARKETING & SALES 46
5.2.5 POST-SALES MONITORING 46
6 GLOBAL URINALYSIS TEST MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 47
6.2 CONSUMABLES 48
6.2.1 PREGNANCY & FERTILITY KITSC 49
6.2.2 DIPSTICKS 50
6.2.3 DISPOSABLES REAGENTS 50
6.2.4 REAGENTS 51
6.3 INSTRUMENTS 51
6.3.1 AUTOMATED URINE ANALYZERS 52
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 56
6.3.3 POINT-OF-CARE URINE ANALYZERS 57
7 GLOBAL URINALYSIS TEST MARKET, TEST TYPE
7.1 OVERVIEW 58
7.2 SEDIMENT ANALYSIS 59
7.3 BIOCHEMICAL ANALYSIS 60
7.3.1 LABORATORY TESTS 61
7.3.2 POINT-OF-CARE TESTS 61
7.4 PREGNANCY AND FERTILITY TESTS 62
8 GLOBAL URINALYSIS TEST MARKET, APPLICATION
8.1 OVERVIEW 63
8.2 DISEASE DIAGNOSIS 64
8.2.1 KIDNEY DISEASES 65
8.2.2 DIABETES 66
8.2.3 URINARY TRACT INFECTIONS 67
8.3 PREGNANCY & FERTILITY 68
9 GLOBAL URINALYSIS TEST MARKET, END USER
9.1 OVERVIEW 69
9.2 HOSPITALS AND CLINICS 70
9.3 DIAGNOSTIC LABORATORIES 71
9.4 HOME CARE SETTINGS 72
9.5 OTHERS 72
10 GLOBAL URINALYSIS TEST MARKET, BY REGION
10.1 OVERVIEW 73
10.2 AMERICAS 75
10.2.1 NORTH AMERICA 80
10.2.2 LATIN AMERICA 93
10.3 EUROPE 98
10.3.1 WESTERN EUROPE 103
10.3.2 EASTERN EUROPE 134
10.4 ASIA-PACIFIC 139
10.4.1 CHINA 144
10.4.2 JAPAN 148
10.4.3 INDIA 152
10.4.4 AUSTRALIA 157
10.4.5 SOUTH KOREA 161
10.4.6 REST OF ASIA-PACIFIC 165
10.5 MIDDLE EAST & AFRICA 170
10.5.1 MIDDLE EAST 175
10.5.2 AFRICA 179
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 183
11.2 COMPETITIVE BENCHMARKING 184
11.3 GLOBAL URINALYSIS TEST MARKET, COMPANY SHARE ANALYSIS, 2018 186
11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL URINALYSIS TEST MARKET 186
11.5 KEY DEVELOPMENT ANALYSIS 187
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 187
11.6.1 CONTRACTS & AGREEMENTS 187
11.6.2 MERGER & ACQUISITION 188
11.6.3 NEW PRODUCT LAUNCH 188
11.6.4 EXPANSIONS 188
11.6.5 APPROVALS 189
12 COMPANY PROFILES
12.1 ABBOTT LABORATORIES 190
12.1.1 COMPANY OVERVIEW 190
12.1.2 FINANCIAL OVERVIEW 190
12.1.3 PRODUCTS/SERVICES OFFERED 191
12.1.4 ABBOTT LABORATORIES: KEY DEVELOPMENTS 191
12.1.5 SWOT ANALYSIS 191
12.1.6 KEY STRATEGIES 191
12.2 BIO-RAD LABORATORIES, INC. 192
12.2.1 COMPANY OVERVIEW 192
12.2.2 FINANCIAL OVERVIEW 192
12.2.3 PRODUCTS/SERVICES OFFERED 193
12.2.4 KEY DEVELOPMENTS 193
12.2.5 SWOT ANALYSIS 193
12.2.6 KEY STRATEGIES 194
12.3 BECKMAN COULTER INC. 195
12.3.1 COMPANY OVERVIEW 195
12.3.2 FINANCIAL OVERVIEW 195
12.3.3 PRODUCTS/SERVICES OFFERED 196
12.3.4 KEY DEVELOPMENTS 196
12.3.5 SWOT ANALYSIS 196
12.3.6 KEY STRATEGIES 197
12.4 F. HOFFMANN-LA ROCHE LTD 198
12.4.1 COMPANY OVERVIEW 198
12.4.2 FINANCIAL OVERVIEW 198
12.4.3 PRODUCTS/SERVICES OFFERED 199
12.4.4 KEY DEVELOPMENTS 199
12.4.5 SWOT ANALYSIS 199
12.4.6 KEY STRATEGIES 199
12.5 SIEMENS HEALTHINEERS 200
12.5.1 COMPANY OVERVIEW 200
12.5.2 FINANCIAL OVERVIEW 200
12.5.3 PRODUCTS/SERVICES OFFERED 201
12.5.4 KEY DEVELOPMENTS 201
12.5.5 SWOT ANALYSIS 202
12.5.6 KEY STRATEGIES 202
12.6 EKF DIAGNOSTICS 203
12.6.1 COMPANY OVERVIEW 203
12.6.2 FINANCIAL OVERVIEW 203
12.6.3 PRODUCTS/SERVICES OFFERED 204
12.6.4 KEY DEVELOPMENTS 204
12.6.5 SWOT ANALYSIS 204
12.6.6 KEY STRATEGIES 205
12.7 ARKRAY, INC. 206
12.7.1 COMPANY OVERVIEW 206
12.7.2 ARKRAY, INC.: FINANCIAL OVERVIEW 206
12.7.3 PRODUCTS/SERVICES OFFERED 206
12.7.4 KEY DEVELOPMENTS 206
12.7.5 SWOT ANALYSIS 207
12.7.6 KEY STRATEGIES 207
12.8 TRINITY BIOTECH PLC 208
12.8.1 COMPANY OVERVIEW 208
12.8.2 FINANCIAL OVERVIEW 208
12.8.3 PRODUCTS/SERVICES OFFERED 209
12.8.4 KEY DEVELOPMENTS 209
12.8.5 SWOT ANALYSIS 209
12.8.6 KEY STRATEGIES 209
12.9 ANALYTICON BIOTECHNOLOGIES AG 210
12.9.1 COMPANY OVERVIEW 210
12.9.2 FINANCIAL OVERVIEW 210
12.9.3 PRODUCTS/SERVICES OFFERED 210
12.9.4 KEY DEVELOPMENTS 210
12.9.5 SWOT ANALYSIS 211
12.9.6 KEY STRATEGIES 211
12.10 77 ELEKTRONIKA KFT. 212
12.10.1 COMPANY OVERVIEW 212
12.10.2 FINANCIAL OVERVIEW 212
12.10.3 PRODUCTS/SERVICES OFFERED 212
12.10.4 KEY DEVELOPMENTS 212
12.10.5 SWOT ANALYS 213
12.10.6 KEY STRATEGIES 213
12.11 YD DIAGNOSTICS 214
12.11.1 COMPANY OVERVIEW 214
12.11.2 FINANCIAL OVERVIEW 214
12.11.3 PRODUCTS/SERVICES OFFERED 214
12.11.4 KEY DEVELOPMENTS 214
12.11.5 SWOT ANALYSIS 215
12.11.6 KEY STRATEGIES 215
12.12 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD 216
12.12.1 COMPANY OVERVIEW 216
12.12.2 FINANCIAL OVERVIEW 216
12.12.3 PRODUCTS/SERVICES OFFERED 216
12.12.4 KEY DEVELOPMENTS 216
12.12.5 SWOT ANALYS 217
12.12.6 KEY STRATEGIES 217
12.13 ERBA MANNHEIM 218
12.13.1 COMPANY OVERVIEW 218
12.13.2 FINANCIAL OVERVIEW 218
12.13.3 PRODUCTS/SERVICES OFFERED 218
12.13.4 KEY DEVELOPMENTS 218
12.13.5 SWOT ANALYS 219
12.13.6 KEY STRATEGIES 219
12.14 CARDINAL HEALTH 220
12.14.1 COMPANY OVERVIEW 220
12.14.2 FINANCIAL OVERVIEW 220
12.14.3 PRODUCTS/SERVICES OFFERED 221
12.14.4 KEY DEVELOPMENTS 221
12.14.5 SWOT ANALYSIS 221
12.14.6 KEY STRATEGY 221
12.15 THERMO FISHER SCIENTIFIC INC. 222
12.15.1 COMPANY OVERVIEW 222
12.15.2 FINANCIAL OVERVIEW 222
12.15.3 PRODUCTS/SERVICES OFFERED 223
12.15.4 KEY DEVELOPMENTS 223
12.15.5 SWOT ANALYSIS 223
12.15.6 KEY STRATEGIES 223
12.16 QUIDEL CORPORATION 224
12.16.1 COMPANY OVERVIEW 224
12.16.2 FINANCIAL OVERVIEW 224
12.16.3 PRODUCTS/SERVICES OFFERED 225
12.16.4 KEY DEVELOPMENTS 225
12.16.5 SWOT ANALYSIS 225
12.16.6 KEY STRATEGIES 225
12.17 SYSMEX CORPORATION 226
12.17.1 COMPANY OVERVIEW 226
12.17.2 FINANCIAL OVERVIEW 226
12.17.3 PRODUCTS/SERVICES OFFERED 227
12.17.4 KEY DEVELOPMENTS 227
12.17.5 SWOT ANALYS 227
12.17.6 KEY STRATEGIES 228
12.18 ACON LABORATORIES, INC. 229
12.18.1 COMPANY OVERVIEW 229
12.18.2 FINANCIAL OVERVIEW 229
12.18.3 PRODUCTS/SERVICES OFFERED 229
12.18.4 KEY DEVELOPMENTS 229
12.18.5 SWOT ANALYSIS 230
12.18.6 KEY STRATEGIES 230
12.19 BECTON, DICKINSON AND COMPANY 231
12.19.1 COMPANY OVERVIEW 231
12.19.2 FINANCIAL OVERVIEW 231
12.19.3 PRODUCTS/SERVICES OFFERED 232
12.19.4 KEY DEVELOPMENTS 232
12.19.5 SWOT ANALYS 232
12.19.6 KEY STRATEGIES 232
12.20 URIT MEDICAL ELECTRONIC C0., LTD 233
12.20.1 COMPANY OVERVIEW 233
12.20.2 FINANCIAL OVERVIEW 233
12.20.3 PRODUCTS/SERVICES OFFERED 233
12.20.4 KEY DEVELOPMENTS 233
12.20.5 SWOT ANALYSIS 234
12.20.6 KEY STRATEGIES 234
12.21 DIRUI 235
12.21.1 COMPANY OVERVIEW 235
12.21.2 FINANCIAL OVERVIEW 235
12.21.3 PRODUCTS/SERVICES OFFERED 235
12.21.4 KEY DEVELOPMENTS 235
12.21.5 SWOT ANALYS 236
12.21.6 KEY STRATEGIES 236
13 APPENDIX
13.1 REFERENCES 237
13.2 RELATED REPORTS 237
